Cargando…

Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis

IMPORTANCE: Prurigo nodularis (PN) is a chronic heterogeneous inflammatory skin disease. OBJECTIVE: To elucidate which components of type 2 inflammation are dysregulated systemically in PN. DESIGN: Whole blood was obtained from PN patients with uncontrolled disease and control patients without pruri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parthasarathy, Varsha, Cravero, Karen, Deng, Junwen, Sun, Zhe, Engle, Sarah M., Auxier, Autum N., Hahn, Nathan, Sims, Jonathan T., Okragly, Angela J., Alphonse, Martin P., Kwatra, Shawn G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763609/ https://www.ncbi.nlm.nih.gov/pubmed/36561717 http://dx.doi.org/10.3389/fmed.2022.1011142

Ejemplares similares

Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis
por: JU, Teresa, et al.
Publicado: (2023)

Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab
por: Deng, Junwen, et al.
Publicado: (2023)

Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
por: Deng, Junwen, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis
por: Patel, Jay R., et al.
Publicado: (2023)

Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: A multicenter cohort study
por: Cornman, Hannah L., et al.
Publicado: (2023)

Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis
por: Rajeh, Ahmad, et al.
Publicado: (2023)

Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis
por: Kwon, Christina D., et al.
Publicado: (2019)

Inpatient Burden of Prurigo Nodularis in the United States
por: Whang, Katherine A., et al.
Publicado: (2019)

Dermal Periostin: A New Player in Itch of Prurigo Nodularis
por: HASHIMOTO, Takashi, et al.
Publicado: (2021)

Patient Perspectives on Living With Severe Prurigo Nodularis
por: Rodriguez, Danielle, et al.
Publicado: (2023)

Association between Prurigo Nodularis and Etiologies of Peripheral Neuropathy: Suggesting a Role for Neural Dysregulation in Pathogenesis
por: Hughes, John-Douglas Matthew, et al.
Publicado: (2020)

Prurigo nodularis after acupuncture
por: Almazan, Timothy Hermosura, et al.
Publicado: (2015)

Dermatoscopic Features of Prurigo Nodularis
por: Nair, Pragya A., et al.
Publicado: (2019)

Treatment-resistant prurigo nodularis
por: Kolli, Sree S, et al.
Publicado: (2019)

Immunotargets and Therapy for Prurigo Nodularis
por: Labib, Angelina, et al.
Publicado: (2022)

Prevalence of Prurigo Nodularis in Poland
por: RYCZEK, Anna, et al.
Publicado: (2020)

Skin Microbiome in Prurigo Nodularis
por: Tutka, Klaudia, et al.
Publicado: (2023)

Increased IL-31 expression in serum and tissue protein in prurigo nodularis
por: Chaowattanapanit, Suteeraporn, et al.
Publicado: (2022)

Treatment-resistant prurigo nodularis: challenges and solutions
por: Kowalski, Eric H, et al.
Publicado: (2019)

The Prevalence of Psychiatric Comorbidity in Patients with Prurigo Nodularis
por: Dhawan, Lovee, et al.
Publicado: (2018)

Prurigo Nodularis after Radiotherapy: An Isoradiotopic Response?
por: Krammer, Caspar Weel, et al.
Publicado: (2018)

Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019)

Prurigo nodularis in vitiligo patches: An unusual observation
por: Saleh, Karim
Publicado: (2020)

A Case of Prurigo Nodularis Treating by Acupuncture
por: Wu, Dan, et al.
Publicado: (2021)

Tofacitinib for Prurigo Nodularis: A Case Report
por: Peng, Changlan, et al.
Publicado: (2022)

Acral Prurigo Nodularis: A Case Report
por: Albinhamad, Abdulaziz, et al.
Publicado: (2022)

Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis
por: Kwatra, Shawn G., et al.
Publicado: (2023)

Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter]
por: Kowalski, Eric H, et al.
Publicado: (2019)

Biopsychosocial Factors Associated with Prurigo Nodularis in Endogenous Eczema
por: Oh, Choon Chiat, et al.
Publicado: (2015)

An unusual case of multibacillary leprosy mimicking prurigo nodularis
por: Noormohammadpour, Pedram, et al.
Publicado: (2020)

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
por: Bloomstein, Joshua D., et al.
Publicado: (2021)

Abnormal Levels of Cortisol and Cortisone in Patients with Prurigo Nodularis
por: Chu, Liuxi, et al.
Publicado: (2021)

Abnormal keratin expression pattern in prurigo nodularis epidermis
por: Yang, L. L., et al.
Publicado: (2021)

Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities
por: Lanza, Giuseppe, et al.
Publicado: (2021)

Impact of Itch on Sleep Disturbance in Patients with Prurigo Nodularis
por: GWILLIM, Eran C., et al.
Publicado: (2021)

Comorbidities of Prurigo Nodularis in Finland Between 1996 and 2019
por: WIKSTRÖM, Kristian, et al.
Publicado: (2021)

Morphea Profunda Masquerading as Prurigo Nodularis: An Uncommon Presentation
por: Rao, Angoori G., et al.
Publicado: (2022)

Dupilumab for the treatment of prurigo nodularis: A systematic review
por: Cao, Peng, et al.
Publicado: (2023)

Risk of incident sleep disorders in patients with prurigo nodularis: A population-level analysis using The Health Improvement Network
por: Joel, Marina Z., et al.
Publicado: (2023)

Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments
por: Bewley, Anthony, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bt6j2tqq2vefspghhqrsnl7nk1